Yes, this stock will face an uphill battle for months and months to come. Huge number of shares, no money, OTC and no institutional support . And on the top of all this, our product presents enormous, unprecedented danger for powerful Big Pharma transnationals and their political power network. Life will not be easy for us, to say the least.